Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Titel:
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Auteur:
Sharma, Mukul Molina, Carlos A Toyoda, Kazunori Bereczki, Daniel Bangdiwala, Shrikant I Kasner, Scott E Lutsep, Helmi L Tsivgoulis, Georgios Ntaios, George Czlonkowska, Anna Shuaib, Ashfaq Amarenco, Pierre Endres, Matthias Yoon, Byung-Woo Tanne, David Toni, Danilo Yperzeele, Laetitia von Weitzel-Mudersbach, Paul Sampaio Silva, Gisele Avezum, Alvaro Dawson, Jesse Strbian, Daniel Tatlisumak, Turgut Eckstein, Jens Ameriso, Sebastián F Weber, Joerg R Sandset, Else Charlotte Goar Pogosova, Nana Lavados, Pablo M Arauz, Antonio Gailani, David Diener, Hans-Christoph Bernstein, Richard A Cordonnier, Charlotte Kahl, Anja Abelian, Grigor Donovan, Mark Pachai, Chahin Li, Danshi Hankey, Graeme J